» Articles » PMID: 30153274

OmpA-like Proteins of Porphyromonas Gingivalis Contribute to Serum Resistance and Prevent Toll-like Receptor 4-mediated Host Cell Activation

Overview
Journal PLoS One
Date 2018 Aug 29
PMID 30153274
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Porphyromonas gingivalis possesses various abilities to evade and disrupt host immune responses, by which it acts as an important periodontal pathogen. P. gingivalis produces outer membrane protein A (OmpA)-like proteins (OmpALPs), Pgm6 and Pgm7, as major O-linked glycoproteins, but their pathological roles in P. gingivalis infection are largely unknown. Here, we report that OmpALP-deficient strains of P. gingivalis show an enhanced stimulatory activity in coculture with host cells. Such an altered ability of the OmpALP-deficient strains was found to be due to their impaired survival in coculture and the release of LPS from dead bacterial cells to stimulate Toll-like receptor 4 (TLR4). Further analyses revealed that the OmpALP-deficient strains were inviable in serum-containing media although they grew normally in the bacterial medium. The wild-type strain was able to grow in 90% normal human serum, while the OmpALP-deficient strains did not survive even at 5%. The OmpALP-deficient strains did not survive in heat-inactivated serum, but they gained the ability to survive and grow in proteinase K-treated serum. Of note, the sensitivity of the OmpALP-deficient strains to the bactericidal activity of human β-defensin 3 was increased as compared with the WT. Thus, this study suggests that OmpALPs Pgm6 and Pgm7 are important for serum resistance of P. gingivalis. These proteins prevent bacterial cell destruction by serum and innate immune recognition by TLR4; this way, P. gingivalis may adeptly colonize serum-containing gingival crevicular fluids and subgingival environments.

Citing Articles

OmpA-Like Proteins of Mediate Resistance to the Antimicrobial Peptide LL-37.

Horie T, Inomata M, Into T J Pathog. 2019; 2018:2068435.

PMID: 30687554 PMC: 6327258. DOI: 10.1155/2018/2068435.

References
1.
Slaney J, Gallagher A, Aduse-Opoku J, Pell K, Curtis M . Mechanisms of resistance of Porphyromonas gingivalis to killing by serum complement. Infect Immun. 2006; 74(9):5352-61. PMC: 1594826. DOI: 10.1128/IAI.00304-06. View

2.
Coats S, Do C, Karimi-Naser L, Braham P, Darveau R . Antagonistic lipopolysaccharides block E. coli lipopolysaccharide function at human TLR4 via interaction with the human MD-2 lipopolysaccharide binding site. Cell Microbiol. 2007; 9(5):1191-202. DOI: 10.1111/j.1462-5822.2006.00859.x. View

3.
Inomata M, Into T, Murakami Y . Suppressive effect of the antimicrobial peptide LL-37 on expression of IL-6, IL-8 and CXCL10 induced by Porphyromonas gingivalis cells and extracts in human gingival fibroblasts. Eur J Oral Sci. 2010; 118(6):574-81. DOI: 10.1111/j.1600-0722.2010.00775.x. View

4.
Into T, Inomata M, Niida S, Murakami Y, Shibata K . Regulation of MyD88 aggregation and the MyD88-dependent signaling pathway by sequestosome 1 and histone deacetylase 6. J Biol Chem. 2010; 285(46):35759-69. PMC: 2975200. DOI: 10.1074/jbc.M110.126904. View

5.
Schenkein H, Genco R . Gingival fluid and serum in periodontal diseases. I. Quantitative study of immunoglobulins, complement components, and other plasma proteins. J Periodontol. 1977; 48(12):772-7. DOI: 10.1902/jop.1977.48.12.772. View